MedTrace Logo

Carotid Endarterectomy and Carotid Artery Stenting in Brazil

NCT02538276 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-05-03

No results posted yet for this study

Summary

Cerebrovascular disease is a leading cause of death and the leading cause of serious long-term disability. Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are alternative strategies for stroke prevention in patients with atherosclerotic carotid disease.The safety and efficacy of CAS compared to CEA still remains questioned, and CEA has been considered to the first-line treatment of carotid stenosis in worldwide. The purpose of this study is to compare the practice and outcomes of CAS and CEA in a real world setting at Public University Hospitals in Brazil.

Conditions

  • Arterial Diseases, Carotid

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • EDWALDO E JOVILIANO, MD; PHD · University of Sao Paulo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2018-07-31
Completion
2019-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02538276 on ClinicalTrials.gov